Vanda Pharmaceuticals Inc. (VNDA)
USD 4.55
(-3.81%)
USD 4.55
(-3.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 192.64 Million | 254.38 Million | 268.68 Million | 248.16 Million | 227.18 Million | 193.11 Million |
| Cost of Revenue | 14.79 Million | 24.28 Million | 25.62 Million | 23.36 Million | 24.48 Million | 20.5 Million |
| Gross Profit | 177.84 Million | 230.1 Million | 243.05 Million | 224.8 Million | 202.7 Million | 172.61 Million |
| Operating Expenses | 191.79 Million | 223.77 Million | 200.88 Million | 197.56 Million | 179.89 Million | 150.87 Million |
| Selling, General and Administrative Expenses | 112.88 Million | 136.48 Million | 124.04 Million | 140.51 Million | 129.73 Million | 105.75 Million |
| Research and Development Expenses | 76.82 Million | 85.77 Million | 75.36 Million | 55.57 Million | 48.64 Million | 43.59 Million |
| Other Expenses | 2.09 Million | 1.51 Million | 1.47 Million | 1.47 Million | 1.5 Million | 3.6 Million |
| Cost and Expenses | 206.59 Million | 248.05 Million | 226.51 Million | 220.92 Million | 204.37 Million | 171.38 Million |
| Operating Income | -13.95 Million | 6.32 Million | 42.16 Million | 27.23 Million | 22.81 Million | 21.73 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.83 Million | 5.02 Million | 9.21 Million | 8.31 Million | -86.52 Million | 138 Thousand |
| Earnings before Tax | 6.33 Million | 11.3 Million | 42.36 Million | 31.65 Million | 29.02 Million | 25.34 Million |
| Net Income | 2.5 Million | 6.27 Million | 33.15 Million | 23.33 Million | 115.55 Million | 25.2 Million |
| Earnings Per Share Basic | 0.04 | 0.11 | 0.60 | 0.43 | 2.17 | 0.50 |
| Earnings Per Share Diluted | 0.04 | 0.11 | 0.58 | 0.42 | 2.11 | 0.48 |
| Weighted Average Shares Outstanding | 57.38 Million | 56.46 Million | 55.54 Million | 54.42 Million | 53.13 Million | 50.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 57.55 Million | 56.98 Million | 56.92 Million | 55.19 Million | 54.84 Million | 53.04 Million |
| Gross Margin | 0.92 | 0.90 | 0.90 | 0.91 | 0.89 | 0.89 |
| EBIT Margin | -0.06 | 0.03 | 0.16 | 0.12 | 0.11 | 0.12 |
| Profit Margin | 0.01 | 0.02 | 0.12 | 0.09 | 0.51 | 0.13 |
| EBITDA | -10.94 Million | 9.06 Million | 45 Million | 30.1 Million | 25.7 Million | 24.69 Million |
| Earnings Before Tax Margin | -0.07 | 0.02 | 0.16 | 0.11 | 0.10 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 50.47 Million | 47.46 Million | 192.64 Million | 45.27 Million | 38.81 Million | 46.05 Million |
| Cost of Revenue | 4.48 Million | 5.45 Million | 16.88 Million | 3.46 Million | 3.06 Million | 3.49 Million |
| Gross Profit | 45.98 Million | 42 Million | 175.75 Million | 41.81 Million | 35.75 Million | 42.55 Million |
| Operating Expenses | 56.13 Million | 51.23 Million | 189.7 Million | 48.9 Million | 41.74 Million | 45.42 Million |
| Selling, General and Administrative Expenses | 39.47 Million | 30.08 Million | - | 23.61 Million | 24.76 Million | 28.39 Million |
| Research and Development Expenses | 16.66 Million | 21.15 Million | - | 24.33 Million | 16.6 Million | 16.64 Million |
| Other Expenses | 4.63 Million | 4.57 Million | 20.29 Million | 5.43 Million | 5.87 Million | 5.45 Million |
| Cost and Expenses | 60.62 Million | 56.69 Million | 206.59 Million | 52.36 Million | 44.81 Million | 48.92 Million |
| Operating Income | -10.14 Million | -9.23 Million | -13.95 Million | -7.09 Million | -5.99 Million | -2.86 Million |
| Interest Expense | - | - | - | 3.52 Million | - | - |
| Income Tax Expense | -998 Thousand | -518 Thousand | 3.83 Million | 739 Thousand | -257 Thousand | 1.07 Million |
| Earnings before Tax | -5.51 Million | -4.66 Million | 6.33 Million | -1.66 Million | -120 Thousand | 2.59 Million |
| Net Income | -4.51 Million | -4.14 Million | 2.5 Million | -2.4 Million | 137 Thousand | 1.52 Million |
| Earnings Per Share Basic | -0.08 | -0.07 | - | -0.04 | 0.00 | 0.03 |
| Earnings Per Share Diluted | -0.08 | -0.07 | - | -0.04 | 0.00 | 0.03 |
| Weighted Average Shares Outstanding | 58.22 Million | 57.76 Million | 57.38 Million | 57.53 Million | 57.51 Million | 57.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.22 Million | 57.76 Million | 57.55 Million | 57.53 Million | 57.59 Million | 57.53 Million |
| Gross Margin | 0.91 | 0.89 | 0.91 | 0.92 | 0.92 | 0.92 |
| EBIT Margin | -0.16 | -0.15 | - | -0.13 | -0.14 | -0.05 |
| Profit Margin | -0.09 | -0.09 | 0.01 | -0.05 | 0.00 | 0.03 |
| EBITDA | -8.17 Million | -7.01 Million | - | -5.93 Million | -5.61 Million | -2.48 Million |
| Earnings Before Tax Margin | -0.20 | -0.19 | -0.07 | -0.16 | -0.15 | -0.06 |
0J1G
3021
JWL
3816
FNMAS
IDP